Hydrogel Delivery of Stem Cell Secreted Factors for Damaged Tissue
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for damaged tissue, particularly neurotrophic keratopathy, are inefficient and require prolonged administration, leading to erratic healing responses and increased risk of infection, scarring, and blindness, with a lack of a clinically available, rapid-onset biopharmacologic therapy.
Innovation Solution
The use of biocompatible gel carriers, such as uncrosslinked and crosslinked hydrogels, to deliver secreted factors from stem cells directly to damaged tissue, enhancing wound healing by immobilizing and concentrating these factors at the tissue surface.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If topical growth factors are applied frequently (e.g., four times daily), then therapeutic effect is maintained, but treatment complexity and patient burden increase
Solution Approach 1:
The patent applies preliminary action by pre-encapsulating growth factors in hydrogel carriers that are applied once to the corneal surface. The hydrogel then releases the growth factors continuously over time, eliminating the need for frequent reapplication. This single application performs the therapeutic function that would otherwise require multiple daily administrations.
Solution Approach 2:
The hydrogel carrier provides continuity of useful action by maintaining a sustained release of growth factors at the corneal surface. The gel matrix slowly releases the encapsulated growth factors over an extended period, ensuring continuous therapeutic presence without requiring repeated applications, thus converting discontinuous dosing into continuous therapeutic action.
2Reliability
If stem cell secreted factors are delivered topically, then tissue regeneration is promoted, but factors are rapidly cleared by tear turnover reducing efficacy
Solution Approach 1:
The patent uses a hydrogel thin film applied to the corneal surface that acts as a flexible barrier. This gel film encapsulates the growth factors and adheres to the corneal epithelium, protecting them from rapid clearance by tear turnover. The thin film structure maintains close contact with the tissue while providing a reservoir that releases factors slowly, extending residence time from minutes to hours.
3Reliability
If amniotic membrane transplantation is used for neurotrophic keratopathy, then wound closure is achieved, but treatment duration is prolonged (two weeks or greater)
Solution Approach 1:
The patent extracts the therapeutic essence (growth factors and secreted molecules) from the amniotic membrane and delivers it in concentrated form through hydrogel carriers. By separating the active therapeutic components from the membrane structure itself, the invention delivers higher concentrations of regenerative factors directly to the wound site, accelerating the healing process while maintaining the reliable wound closure outcome.
4Reliability
If stem cells are transplanted, then tissue regeneration is enhanced, but without required matrix and stimulatory factors, cell survival and integration are limited
Solution Approach 1:
The patent merges stem cell therapy with growth factor delivery by combining transplanted stem cells with hydrogel carriers containing concentrated growth factors and secreted molecules. This combination provides both the regenerative cells and the necessary stimulatory factors and matrix environment, creating a synergistic effect that enhances cell survival, integration, and tissue regeneration compared to cell transplantation alone.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Accelerates healing, reduces scar formation, and promotes nerve regeneration, while minimizing treatment duration and complications, providing a rapid-onset therapeutic effect.
Implementation Method 1
biocompatible gel carriers, such as uncrosslinked and crosslinked hydrogels, to deliver secreted factors from stem cells directly to damaged tissue, enhancing wound healing by immobilizing and concentrating these factors at the tissue surface
Implementation Method 2
immobilizing and concentrating these factors at the tissue surface
Implementation Method 3
crosslinked hydrogels, to deliver secreted factors
Data Source
AI summary
Compositions and methods for repairing or regenerating damaged tissue are disclosed. In particular, the invention relates to methods of delivering secreted factors from stem cells to tissues in order to immobilize and concentrate such secreted factors at or under the surface of damaged tissue to promote tissue regeneration.